News

Actions

Valley woman hosting benefit to raise money for Colorado toddler with rare disease

Posted at 12:56 PM, Jul 23, 2019
and last updated 2019-07-23 14:56:15-04

Click here for updates on this story

    PHOENIX, AZ (KNXV) — A Valley woman is trying to help raise more than two million dollars to pay for a treatment that could save a young girl’s life.

Tracey Felten is organizing a benefit concert in Phoenix in August to help raise roughly $2.1 million.

Her friend’s daughter, Maisie, lives in Colorado and has Spinal Muscular Atrophy Type 1. The condition involves muscle atrophy and difficulty breathing and makes it tough for impacted children to live past the age of two. Maisie turns two in December.

“It upsets me very much to know that there’s a cure out there to help her, but it’s money that’s in the way,” Felten said.

Maisie’s family told ABC15 a new gene therapy treatment that could stop the disease’s progression wasn’t approved by their insurance. Zolgensma, a treatment for SMA patients under the age of two, comes with a price tag of roughly $2.1 million.

Maisie’s mother told ABC15 the treatment would make a significant impact.

“Every day is a struggle because we’re not guaranteed tomorrow with her,” said Maisie’s mother, Ciji Green.

Green says her daughter is currently on the drug Spinraza, which slows down the disease’s progression. Green says Zolgensma could halt the progression and perhaps undue some of the symptoms.

“I want to keep [Maisie] as long as I possibly can,” said an emotional Green.

Now the challenge is raising a large amount of money for the treatment.

A GoFundMe page has been set up to help, and Felten hopes to draw a big crowd at the benefit concert in Phoenix on August 24th.

“We’re doing everything that we can,” Felten said. “At least we’ll know in the end, whichever way it goes, that we did everything that we could to save her.”

Please note: This content carries a strict local market embargo. If you share the same market as the contributor of this article, you may not use it on any platform.